CD8B and lung carcinoma: In many respects, the high B cell/DC1 infiltration shaped an inflamed and immune-activated TME of lung cancer tissues, including adaptive immune resistance markers, CD8A, CD8B, immunomodulators (immunostimulants, MHC, receptors, and chemokines), and immune-related pathways.